Global Lisinopril Market Research Report 2021

Global Lisinopril Market Research Report 2021

Table of Contents
1 Lisinopril Market Overview
1.1 Product Overview and Scope of Lisinopril
1.2 Lisinopril Segment by Type
1.2.1 Global Lisinopril Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Lisinopril Segment by Application
1.3.1 Lisinopril Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Revenue 2016-2027
1.4.2 Global Lisinopril Sales 2016-2027
1.4.3 Lisinopril Market Size by Region: 2016 Versus 2021 Versus 2027
2 Lisinopril Market Competition by Manufacturers
2.1 Global Lisinopril Sales Market Share by Manufacturers (2016-2021)
2.2 Global Lisinopril Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Lisinopril Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Lisinopril Manufacturing Sites, Area Served, Product Type
2.5 Lisinopril Market Competitive Situation and Trends
2.5.1 Lisinopril Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lisinopril Players Market Share by Revenue
2.5.3 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lisinopril Retrospective Market Scenario by Region
3.1 Global Lisinopril Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Lisinopril Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Lisinopril Market Facts & Figures by Country
3.3.1 North America Lisinopril Sales by Country
3.3.2 North America Lisinopril Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Lisinopril Market Facts & Figures by Country
3.4.1 Europe Lisinopril Sales by Country
3.4.2 Europe Lisinopril Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lisinopril Market Facts & Figures by Region
3.5.1 Asia Pacific Lisinopril Sales by Region
3.5.2 Asia Pacific Lisinopril Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Lisinopril Market Facts & Figures by Country
3.6.1 Latin America Lisinopril Sales by Country
3.6.2 Latin America Lisinopril Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lisinopril Market Facts & Figures by Country
3.7.1 Middle East and Africa Lisinopril Sales by Country
3.7.2 Middle East and Africa Lisinopril Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Lisinopril Historic Market Analysis by Type
4.1 Global Lisinopril Sales Market Share by Type (2016-2021)
4.2 Global Lisinopril Revenue Market Share by Type (2016-2021)
4.3 Global Lisinopril Price by Type (2016-2021)
5 Global Lisinopril Historic Market Analysis by Application
5.1 Global Lisinopril Sales Market Share by Application (2016-2021)
5.2 Global Lisinopril Revenue Market Share by Application (2016-2021)
5.3 Global Lisinopril Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Actavis Elizabeth
6.1.1 Actavis Elizabeth Corporation Information
6.1.2 Actavis Elizabeth Description and Business Overview
6.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Actavis Elizabeth Product Portfolio
6.1.5 Actavis Elizabeth Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Apotex Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Aurobindo Pharma Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Ivax Pharmaceuticals
6.4.1 Ivax Pharmaceuticals Corporation Information
6.4.2 Ivax Pharmaceuticals Description and Business Overview
6.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ivax Pharmaceuticals Product Portfolio
6.4.5 Ivax Pharmaceuticals Recent Developments/Updates
6.5 Lek Pharmaceuticals
6.5.1 Lek Pharmaceuticals Corporation Information
6.5.2 Lek Pharmaceuticals Description and Business Overview
6.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lek Pharmaceuticals Product Portfolio
6.5.5 Lek Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lupin Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Corporation Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Pharmaceuticals Product Portfolio
6.7.5 Mylan Pharmaceuticals Recent Developments/Updates
6.8 Ranbaxy Pharmaceuticals
6.8.1 Ranbaxy Pharmaceuticals Corporation Information
6.8.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ranbaxy Pharmaceuticals Product Portfolio
6.8.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novartis Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Corporation Information
6.10.2 Teva Pharmaceuticals Description and Business Overview
6.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Teva Pharmaceuticals Product Portfolio
6.10.5 Teva Pharmaceuticals Recent Developments/Updates
6.11 Vintage Pharmaceuticals
6.11.1 Vintage Pharmaceuticals Corporation Information
6.11.2 Vintage Pharmaceuticals Lisinopril Description and Business Overview
6.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Vintage Pharmaceuticals Product Portfolio
6.11.5 Vintage Pharmaceuticals Recent Developments/Updates
6.12 Watson Laboratories
6.12.1 Watson Laboratories Corporation Information
6.12.2 Watson Laboratories Lisinopril Description and Business Overview
6.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Watson Laboratories Product Portfolio
6.12.5 Watson Laboratories Recent Developments/Updates
6.13 West Ward Pharmaceutical
6.13.1 West Ward Pharmaceutical Corporation Information
6.13.2 West Ward Pharmaceutical Lisinopril Description and Business Overview
6.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.13.4 West Ward Pharmaceutical Product Portfolio
6.13.5 West Ward Pharmaceutical Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Lisinopril Description and Business Overview
6.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Wockhardt Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Merck Research Laboratories
6.15.1 Merck Research Laboratories Corporation Information
6.15.2 Merck Research Laboratories Lisinopril Description and Business Overview
6.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Merck Research Laboratories Product Portfolio
6.15.5 Merck Research Laboratories Recent Developments/Updates
6.16 Astrazeneca
6.16.1 Astrazeneca Corporation Information
6.16.2 Astrazeneca Lisinopril Description and Business Overview
6.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Astrazeneca Product Portfolio
6.16.5 Astrazeneca Recent Developments/Updates
6.17 Alvogen
6.17.1 Alvogen Corporation Information
6.17.2 Alvogen Lisinopril Description and Business Overview
6.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Alvogen Product Portfolio
6.17.5 Alvogen Recent Developments/Updates
6.18 Hikma
6.18.1 Hikma Corporation Information
6.18.2 Hikma Lisinopril Description and Business Overview
6.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Hikma Product Portfolio
6.18.5 Hikma Recent Developments/Updates
6.19 Prinston
6.19.1 Prinston Corporation Information
6.19.2 Prinston Lisinopril Description and Business Overview
6.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Prinston Product Portfolio
6.19.5 Prinston Recent Developments/Updates
6.20 Accord Hlthcare
6.20.1 Accord Hlthcare Corporation Information
6.20.2 Accord Hlthcare Lisinopril Description and Business Overview
6.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Accord Hlthcare Product Portfolio
6.20.5 Accord Hlthcare Recent Developments/Updates
6.21 CASI Pharms
6.21.1 CASI Pharms Corporation Information
6.21.2 CASI Pharms Lisinopril Description and Business Overview
6.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.21.4 CASI Pharms Product Portfolio
6.21.5 CASI Pharms Recent Developments/Updates
6.22 Invagen Pharms
6.22.1 Invagen Pharms Corporation Information
6.22.2 Invagen Pharms Lisinopril Description and Business Overview
6.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Invagen Pharms Product Portfolio
6.22.5 Invagen Pharms Recent Developments/Updates
6.23 SUN Pharm
6.23.1 SUN Pharm Corporation Information
6.23.2 SUN Pharm Lisinopril Description and Business Overview
6.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.23.4 SUN Pharm Product Portfolio
6.23.5 SUN Pharm Recent Developments/Updates
7 Lisinopril Manufacturing Cost Analysis
7.1 Lisinopril Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lisinopril
7.4 Lisinopril Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lisinopril Distributors List
8.3 Lisinopril Customers
9 Lisinopril Market Dynamics
9.1 Lisinopril Industry Trends
9.2 Lisinopril Growth Drivers
9.3 Lisinopril Market Challenges
9.4 Lisinopril Market Restraints
10 Global Market Forecast
10.1 Lisinopril Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lisinopril by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Lisinopril by Type (2022-2027)
10.2 Lisinopril Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Lisinopril by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Lisinopril by Application (2022-2027)
10.3 Lisinopril Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lisinopril by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Lisinopril by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Lisinopril Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Lisinopril Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Lisinopril Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Lisinopril Covered in This Study
Table 5. Global Lisinopril Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Lisinopril Sales Share by Manufacturers (2016-2021)
Table 7. Global Lisinopril Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Lisinopril Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Lisinopril Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Lisinopril Manufacturing Sites and Area Served
Table 11. Manufacturers Lisinopril Product Type
Table 12. Global Lisinopril Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Lisinopril by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lisinopril as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Lisinopril Sales by Region (2016-2021) & (K Units)
Table 16. Global Lisinopril Sales Market Share by Region (2016-2021)
Table 17. Global Lisinopril Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Lisinopril Sales by Country (2016-2021) & (K Units)
Table 19. North America Lisinopril Sales Market Share by Country (2016-2021)
Table 20. North America Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Lisinopril Revenue Market Share by Country (2016-2021)
Table 22. Europe Lisinopril Sales by Country (2016-2021) & (K Units)
Table 23. Europe Lisinopril Sales Market Share by Country (2016-2021)
Table 24. Europe Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Lisinopril Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Lisinopril Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Lisinopril Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Lisinopril Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Lisinopril Revenue Market Share by Region (2016-2021)
Table 30. Latin America Lisinopril Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Lisinopril Sales Market Share by Country (2016-2021)
Table 32. Latin America Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Lisinopril Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Lisinopril Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Lisinopril Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Lisinopril Revenue Market Share by Country (2016-2021)
Table 38. Global Lisinopril Sales (K Units) by Type (2016-2021)
Table 39. Global Lisinopril Sales Market Share by Type (2016-2021)
Table 40. Global Lisinopril Revenue (Million US$) by Type (2016-2021)
Table 41. Global Lisinopril Revenue Share by Type (2016-2021)
Table 42. Global Lisinopril Price (US$/Unit) by Type (2016-2021)
Table 43. Global Lisinopril Sales (K Units) by Application (2016-2021)
Table 44. Global Lisinopril Sales Market Share by Application (2016-2021)
Table 45. Global Lisinopril Revenue (Million US$) by Application (2016-2021)
Table 46. Global Lisinopril Revenue Share by Application (2016-2021)
Table 47. Global Lisinopril Price (US$/Unit) by Application (2016-2021)
Table 48. Actavis Elizabeth Corporation Information
Table 49. Actavis Elizabeth Description and Business Overview
Table 50. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Actavis Elizabeth Lisinopril Product
Table 52. Actavis Elizabeth Recent Developments/Updates
Table 53. Apotex Corporation Information
Table 54. Apotex Description and Business Overview
Table 55. Apotex Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Apotex Lisinopril Product
Table 57. Apotex Recent Developments/Updates
Table 58. Aurobindo Pharma Corporation Information
Table 59. Aurobindo Pharma Description and Business Overview
Table 60. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Aurobindo Pharma Lisinopril Product
Table 62. Aurobindo Pharma Recent Developments/Updates
Table 63. Ivax Pharmaceuticals Corporation Information
Table 64. Ivax Pharmaceuticals Description and Business Overview
Table 65. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Ivax Pharmaceuticals Lisinopril Product
Table 67. Ivax Pharmaceuticals Recent Developments/Updates
Table 68. Lek Pharmaceuticals Corporation Information
Table 69. Lek Pharmaceuticals Description and Business Overview
Table 70. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Lek Pharmaceuticals Lisinopril Product
Table 72. Lek Pharmaceuticals Recent Developments/Updates
Table 73. Lupin Corporation Information
Table 74. Lupin Description and Business Overview
Table 75. Lupin Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Lupin Lisinopril Product
Table 77. Lupin Recent Developments/Updates
Table 78. Mylan Pharmaceuticals Corporation Information
Table 79. Mylan Pharmaceuticals Description and Business Overview
Table 80. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Mylan Pharmaceuticals Lisinopril Product
Table 82. Mylan Pharmaceuticals Recent Developments/Updates
Table 83. Ranbaxy Pharmaceuticals Corporation Information
Table 84. Ranbaxy Pharmaceuticals Description and Business Overview
Table 85. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Ranbaxy Pharmaceuticals Lisinopril Product
Table 87. Ranbaxy Pharmaceuticals Recent Developments/Updates
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Novartis Lisinopril Product
Table 92. Novartis Recent Developments/Updates
Table 93. Teva Pharmaceuticals Corporation Information
Table 94. Teva Pharmaceuticals Description and Business Overview
Table 95. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Teva Pharmaceuticals Lisinopril Product
Table 97. Teva Pharmaceuticals Recent Developments/Updates
Table 98. Vintage Pharmaceuticals Corporation Information
Table 99. Vintage Pharmaceuticals Description and Business Overview
Table 100. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Vintage Pharmaceuticals Lisinopril Product
Table 102. Vintage Pharmaceuticals Recent Developments/Updates
Table 103. Watson Laboratories Corporation Information
Table 104. Watson Laboratories Description and Business Overview
Table 105. Watson Laboratories Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Watson Laboratories Lisinopril Product
Table 107. Watson Laboratories Recent Developments/Updates
Table 108. West Ward Pharmaceutical Corporation Information
Table 109. West Ward Pharmaceutical Description and Business Overview
Table 110. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. West Ward Pharmaceutical Lisinopril Product
Table 112. West Ward Pharmaceutical Recent Developments/Updates
Table 113. Wockhardt Corporation Information
Table 114. Wockhardt Description and Business Overview
Table 115. Wockhardt Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Wockhardt Lisinopril Product
Table 117. Wockhardt Recent Developments/Updates
Table 118. Merck Research Laboratories Corporation Information
Table 119. Merck Research Laboratories Description and Business Overview
Table 120. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Merck Research Laboratories Lisinopril Product
Table 122. Merck Research Laboratories Recent Developments/Updates
Table 123. Astrazeneca Corporation Information
Table 124. Astrazeneca Description and Business Overview
Table 125. Astrazeneca Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Astrazeneca Lisinopril Product
Table 127. Astrazeneca Recent Developments/Updates
Table 128. Alvogen Corporation Information
Table 129. Alvogen Description and Business Overview
Table 130. Alvogen Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Alvogen Lisinopril Product
Table 132. Alvogen Recent Developments/Updates
Table 133. Hikma Corporation Information
Table 134. Hikma Description and Business Overview
Table 135. Hikma Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Hikma Lisinopril Product
Table 137. Hikma Recent Developments/Updates
Table 138. Prinston Corporation Information
Table 139. Prinston Description and Business Overview
Table 140. Prinston Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Prinston Lisinopril Product
Table 142. Prinston Recent Developments/Updates
Table 143. Accord Hlthcare Corporation Information
Table 144. Accord Hlthcare Description and Business Overview
Table 145. Accord Hlthcare Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Accord Hlthcare Lisinopril Product
Table 147. Accord Hlthcare Recent Developments/Updates
Table 148. CASI Pharms Corporation Information
Table 149. CASI Pharms Description and Business Overview
Table 150. CASI Pharms Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. CASI Pharms Lisinopril Product
Table 152. CASI Pharms Recent Developments/Updates
Table 153. Invagen Pharms Corporation Information
Table 154. Invagen Pharms Description and Business Overview
Table 155. Invagen Pharms Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Invagen Pharms Lisinopril Product
Table 157. Invagen Pharms Recent Developments/Updates
Table 158. SUN Pharm Corporation Information
Table 159. SUN Pharm Description and Business Overview
Table 160. SUN Pharm Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. SUN Pharm Lisinopril Product
Table 162. SUN Pharm Recent Developments/Updates
Table 163. Production Base and Market Concentration Rate of Raw Material
Table 164. Key Suppliers of Raw Materials
Table 165. Lisinopril Distributors List
Table 166. Lisinopril Customers List
Table 167. Lisinopril Market Trends
Table 168. Lisinopril Growth Drivers
Table 169. Lisinopril Market Restraints
Table 170. Global Lisinopril Sales Forecast by Type (2022-2027) & (K Units)
Table 171. Global Lisinopril Sales Market Share Forecast by Type (2022-2027)
Table 172. Global Lisinopril Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 173. Global Lisinopril Revenue Market Share Forecast by Type (2022-2027)
Table 174. Global Lisinopril Sales Forecast by Application (2022-2027) & (K Units)
Table 175. Global Lisinopril Sales Market Share Forecast by Application (2022-2027)
Table 176. Global Lisinopril Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 177. Global Lisinopril Revenue Market Share Forecast by Application (2022-2027)
Table 178. Global Lisinopril Sales Forecast by Region (2022-2027) & (K Units)
Table 179. Global Lisinopril Sales Market Share Forecast by Region (2022-2027)
Table 180. Global Lisinopril Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 181. Global Lisinopril Revenue Market Share Forecast by Region (2022-2027)
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lisinopril
Figure 2. Global Lisinopril Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 20mg Product Picture
Figure 7. 30mg Product Picture
Figure 8. 40mg Product Picture
Figure 9. Global Lisinopril Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Drug Store
Figure 12. Global Lisinopril Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lisinopril Market Size 2016-2027 (US$ Million)
Figure 14. Global Lisinopril Sales 2016-2027 (K Units)
Figure 15. Global Lisinopril Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Lisinopril Sales Share by Manufacturers in 2020
Figure 17. Global Lisinopril Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Lisinopril Players: Market Share by Revenue in 2020
Figure 19. Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Lisinopril Sales Market Share by Region (2016-2021)
Figure 21. Global Lisinopril Sales Market Share by Region in 2020
Figure 22. Global Lisinopril Revenue Market Share by Region (2016-2021)
Figure 23. Global Lisinopril Revenue Market Share by Region in 2020
Figure 24. U.S. Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Lisinopril Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Lisinopril by Type (2016-2021)
Figure 49. Sales Market Share of Lisinopril by Application (2016-2021)
Figure 50. Sales Market Share of Lisinopril by Application in 2020
Figure 51. Revenue Share of Lisinopril by Application (2016-2021)
Figure 52. Revenue Share of Lisinopril by Application in 2020
Figure 53. Manufacturing Cost Structure of Lisinopril
Figure 54. Manufacturing Process Analysis of Lisinopril
Figure 55. Lisinopril Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs